Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced
Search Within

Chaitanya Divgi

  • Home
  • Works
  • Groups
  1. "Behavioral Sciences Service"
Formats
  1. Meeting Abstract (1)
Groups
  1. Behavioral Sciences Service (1)
  2. Breast Medicine Service (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Molecular Imaging and Therapy Service (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)
  1. Behavioral Sciences Service (1)
  2. Breast Medicine Service (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Molecular Imaging and Therapy Service (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)
  7. Psychiatry and Behavioral Sciences, Department of (1)
  8. Radiology, Department of (1)
  9. Sloan Kettering Institute Faculty (1)
  10. Solid Tumor Oncology Division (1)

More Groups

Fewer Groups

People
  1. Lale Kostakoglu (1)
  2. Maria Theodoulou-Haber (1)
  3. Steven Larson (1)
  4. Teresa Gilewski (1)
Years
  1. 1994 (1)
Publications
  1. Journal of Nuclear Medicine (1)
Publishers
  1. Society of Nuclear Medicine (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II radioimmunotherapy (RIT) trial with I-131 labeled monoclonal antibody CC49 in TAG-72 expressing breast cancer
    Meeting Abstract

    Kostakoglu, L.; Divgi, C. R.; Gilewski, T.; Theodoulou, M.; Schlom, J.; Larson, S. M.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2022 Memorial Sloan Kettering Cancer Center Library